Cover
Cover - shares | 9 Months Ended | |
Sep. 30, 2023 | Nov. 14, 2023 | |
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Sep. 30, 2023 | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2023 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 001-41344 | |
Entity Registrant Name | METAL SKY STAR ACQUISITION CORPORATION | |
Entity Central Index Key | 0001882464 | |
Entity Tax Identification Number | 00-0000000 | |
Entity Incorporation, State or Country Code | E9 | |
Entity Address, Address Line One | 132 West 31st Street | |
Entity Address, Address Line Two | First Floor | |
Entity Address, City or Town | New York | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10001 | |
City Area Code | (332) | |
Local Phone Number | 237-6141 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Elected Not To Use the Extended Transition Period | false | |
Entity Shell Company | true | |
Entity Common Stock, Shares Outstanding | 6,407,416 | |
Units, each consisting of one Ordinary Share, $0.001 par value, one redeemable warrant, and one right | ||
Title of 12(b) Security | Units, each consisting of one Ordinary Share, $0.001 par value, one redeemable warrant, and one right | |
Trading Symbol | MSSAU | |
Security Exchange Name | NASDAQ | |
Ordinary Shares, $0.001 par value | ||
Title of 12(b) Security | Ordinary Shares, $0.001 par value | |
Trading Symbol | MSSA | |
Security Exchange Name | NASDAQ | |
Redeemable warrants, each warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share | ||
Title of 12(b) Security | Redeemable warrants, each warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share | |
Trading Symbol | MSSAW | |
Security Exchange Name | NASDAQ | |
Rights to receive one-tenth (1/10 | ||
Title of 12(b) Security | Rights to receive one-tenth (1/10th) of one Ordinary Share | |
Trading Symbol | MSSAR | |
Security Exchange Name | NASDAQ |
BALANCE SHEETS (Unaudited)
BALANCE SHEETS (Unaudited) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Current assets: | ||
Cash in escrow | $ 1,164 | $ 178,652 |
Prepaid expense | 21,250 | 39,683 |
Marketable securities held in trust account | 60,787,237 | 116,673,481 |
TOTAL ASSETS | 60,809,651 | 116,891,816 |
Current liabilities: | ||
Accrued expenses | 303,492 | 146,738 |
Due to related party | 190,683 | |
Promissory note - related party | 1,935,248 | 0 |
Deferred underwriting commissions | 2,875,000 | 2,875,000 |
Total Current Liabilities | 5,304,423 | 3,021,738 |
TOTAL LIABILITIES | 5,304,423 | 3,021,738 |
Ordinary shares subject to possible redemption, 5,614,676 and 11,500,000 shares at redemption value at September 30, 2023 and December 31, 2022, respectively | 60,787,237 | 116,673,481 |
Shareholders’ Deficit: | ||
Ordinary shares, $0.001 par value; 50,000,000 shares authorized; 3,205,000 and 3,205,000 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively, excluding 5,614,676 and 11,500,000 shares subject to possible redemption at September 30, 2023 and December 31, 2022, respectively | 3,205 | 3,205 |
Accumulated deficit | (5,285,214) | (2,806,608) |
Total Shareholders’ Deficit | (5,282,009) | (2,803,403) |
TOTAL LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT | $ 60,809,651 | $ 116,891,816 |
BALANCE SHEETS (Unaudited) (Par
BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Temporary Equity, Shares Outstanding | 5,614,676 | 11,500,000 |
Ordinary shares, par value | $ 0.001 | $ 0.001 |
Ordinary shares, shares authorized | 50,000,000 | 50,000,000 |
Ordinary shares, shares issued | 3,205,000 | 3,205,000 |
Ordinary shares, shares outstanding | 3,205,000 | 3,205,000 |
STATEMENTS OF OPERATIONS (Unaud
STATEMENTS OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Formation and operational costs | $ 110,635 | $ 110,104 | $ 598,030 | $ 282,269 |
Loss from operation costs | 110,635 | 110,104 | 598,030 | 282,269 |
Operating loss | (110,635) | (110,104) | (598,030) | (282,269) |
Other income: | ||||
Interest earned on marketable securities held in trust account | 516,036 | 298,932 | 2,065,362 | 459,842 |
Unrealized gained on marketable securities held in trust account | 256,975 | 220,985 | 256,975 | 220,985 |
Total other income | 773,011 | 519,917 | 2,322,337 | 680,827 |
Income before income taxes | 662,376 | 409,813 | 1,724,307 | 398,558 |
Income tax (benefit) expense | ||||
Net income | $ 662,376 | $ 409,813 | $ 1,724,307 | $ 398,558 |
Basic and diluted weighted average shares outstanding - ordinary shares subject to redemption | 5,614,676 | 11,500,000 | 6,110,197 | 7,540,293 |
Basic and diluted net income per share | $ 0.16 | $ 0.04 | $ 0.42 | $ 0.79 |
Basic and diluted weighted average shares outstanding - non redeemable ordinary shares | 3,205,000 | 3,205,000 | 3,205,000 | 3,091,374 |
Basic and diluted net loss per share | $ (0.08) | $ (0.01) | $ (0.27) | $ (1.80) |
STATEMENTS OF CHANGES IN SHAREH
STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Beginning balance, value at Dec. 31, 2021 | $ 2,875 | $ 22,125 | $ (24,850) | $ 150 |
Beginning balance, Shares at Dec. 31, 2021 | 2,875,000 | |||
Net income | (3,550) | (3,550) | ||
Ending balance, value at Mar. 31, 2022 | $ 2,875 | 22,125 | (28,400) | (3,400) |
Ending balance, Shares at Mar. 31, 2022 | 2,875,000 | |||
Issuance of public shares at initial public offering | $ 11,500 | 114,988,500 | 115,000,000 | |
Issuance of public shares at initial public offering, shares | 11,500,000 | |||
Underwriters’ Discount | (5,175,000) | (5,175,000) | ||
Offering costs | (529,741) | (529,741) | ||
Sale of shares to sponsor in private placement | $ 330 | 3,299,670 | 3,300,000 | |
Sale of shares to sponsor in private placement, shares | 330,000 | |||
Initial value of ordinary stock subject to possible redemption | $ (11,500) | (101,188,500) | (101,200,000) | |
Initial value of ordinary stock subject to possible redemption, shares | (11,500,000) | |||
Allocation of offering costs related to redeemable shares | 5,020,172 | 5,020,172 | ||
Accretion of carrying value of redeemable shares to redemption value | (16,437,226) | (2,382,946) | (18,820,172) | |
Subsequent measurement of ordinary shares subject to redemption (interest earned on trust account) | (160,910) | (160,910) | ||
Net income | (7,705) | (7,705) | ||
Ending balance, value at Jun. 30, 2022 | $ 3,205 | (2,579,961) | (2,576,756) | |
Ending balance, Shares at Jun. 30, 2022 | 3,205,000 | |||
Subsequent measurement of ordinary shares subject to redemption (interest earned on trust account) | (519,917) | (519,917) | ||
Net income | 409,813 | 409,813 | ||
Ending balance, value at Sep. 30, 2022 | $ 3,205 | (2,690,065) | (2,686,860) | |
Ending balance, Shares at Sep. 30, 2022 | 3,205,000 | |||
Beginning balance, value at Dec. 31, 2022 | $ 3,205 | (2,806,608) | (2,803,403) | |
Beginning balance, Shares at Dec. 31, 2022 | 3,205,000 | |||
Subsequent measurement of ordinary shares subject to possible redemption (additional funding for business combination extension) | (757,676) | (757,676) | ||
Subsequent measurement of ordinary shares subject to redemption (interest earned on trust account) | (858,920) | (858,920) | ||
Net income | 595,502 | 595,502 | ||
Ending balance, value at Mar. 31, 2023 | $ 3,205 | (3,827,702) | (3,824,497) | |
Ending balance, Shares at Mar. 31, 2023 | 3,205,000 | |||
Subsequent measurement of ordinary shares subject to possible redemption (additional funding for business combination extension) | (561,466) | (561,466) | ||
Subsequent measurement of ordinary shares subject to redemption (interest earned on trust account) | (690,406) | (690,406) | ||
Net income | 466,429 | 466,429 | ||
Ending balance, value at Jun. 30, 2023 | $ 3,205 | (4,613,145) | (4,609,940) | |
Ending balance, Shares at Jun. 30, 2023 | 3,205,000 | |||
Subsequent measurement of ordinary shares subject to possible redemption (additional funding for business combination extension) | (561,434) | (561,434) | ||
Subsequent measurement of ordinary shares subject to redemption (interest earned on trust account) | (773,011) | (773,011) | ||
Net income | 662,376 | 662,376 | ||
Ending balance, value at Sep. 30, 2023 | $ 3,205 | $ (5,285,214) | $ (5,282,009) | |
Ending balance, Shares at Sep. 30, 2023 | 3,205,000 |
STATEMENT OF CASH FLOWS (Unaudi
STATEMENT OF CASH FLOWS (Unaudited) - USD ($) | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cash flows from operating activities: | ||
Net income | $ 1,724,307 | $ 398,558 |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
Interest earned on marketable securities held in trust account | (2,065,362) | (459,842) |
Unrealized gain on marketable securities held in trust account | (256,975) | (220,985) |
Amortization | 76,558 | 78,134 |
Net changes in operating assets & liabilities: | ||
Deferred offering costs | 236,522 | |
Prepaid expenses | (58,125) | (157,500) |
Accrued offering costs | (31,550) | |
Accrued expenses | 156,754 | 78,828 |
Net cash used in operating activities | (422,843) | (77,835) |
Cash flows from investing activities: | ||
Investment of cash in trust account | (1,880,576) | (115,000,000) |
Cash withdrawn from trust account to redeem public shares | 60,089,158 | |
Net cash provided by (used in) investing activities | 58,208,582 | (115,000,000) |
Cash flows from financing activities: | ||
Borrowings from related party | 2,125,931 | |
Proceeds from sale of private placement units | 3,300,000 | |
Proceeds from Sale of Units | 114,700,000 | |
Payment of offering costs | (2,829,741) | |
Redemption of public shares | (60,089,158) | |
Net cash provided by (used in) financing activities | (57,963,227) | 115,170,259 |
Net change in cash and cash equivalents | (177,488) | 92,424 |
Cash and cash equivalents at beginning of period | 178,652 | 95,978 |
Cash and cash equivalents at end of period | 1,164 | 188,402 |
Supplemental disclosure of non-cash investing and financing activities: | ||
Deferred underwriting compensation | 2,875,000 | |
Initial ordinary shares subject to possible redemption | 101,200,000 | |
Reclassification of offering costs related to public shares | (5,020,172) | |
Change in value of ordinary shares subject to redemption | 18,820,172 | |
Subsequent measurement of ordinary shares subject to redemption (interest earned, unrealized gain on trust account and additional funding for business combination extension) | $ 4,202,913 | $ 680,827 |
DESCRIPTION OF ORGANIZATION AND
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS | NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Organization and General Metal Sky Star Acquisition Corporation (the “Company”) is a blank check company incorporated in the Cayman Islands on May 5, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). The Company’s efforts in identifying prospective target businesses will not be limited to a particular geographic region. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company’s sponsor is M-Star Management Corporation, a British Virgin Islands incorporated company (the “Sponsor”). On September 30, 2023, the Company had not yet commenced any operations. All activities through September 30, 2023 relate to the Company’s formation and the initial public offering (“IPO”) and its Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year-end. The Company has up to 22 months from the closing of our initial public offering if we extend the period of time to consummate a Business Combination (the “Combination Period”). If the Company fails to consummate a Business Combination within the Combination Period, it will trigger its automatic winding up, liquidation and subsequent dissolution pursuant to the terms of the Company’s amended and restated memorandum and articles of association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. Accordingly, no vote would be required from the Company’s shareholders to commence such a voluntary winding up, liquidation and subsequent dissolution. On April 5, 2022, the Company consummated the IPO of 11,500,000 1,500,000 10.00 115,000,000 On October 30, 2023 during the Extraordinary General Meeting, the shareholders approved an amendment to the company’s Amended and Restated Memorandum and Articles of Association to extend the date up to six (6) months which the company must consummate a business combination to August 5, 2024. As of September 30, 2023, the Company have approximately 10 months to consummate a business combination if fully extend the period of time as the Amended and Restated Memorandum and Articles of Association. The Trust Account As of April 5, 2022, a total of $ 115,682,250 of the net proceeds from the IPO and the private placement transaction completed with the Sponsor, was deposited in a trust account established for the benefit of the Company’s public shareholders with Wilmington Trust, National Association acting as trustee. On January 26, 2023, an Extraordinary General Meeting of shareholders was held to approve the proposal to amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination twelve (12) times for an additional one (1) month each time from February 5, 2023 to February 5, 2024. In connection with the Extraordinary General Meeting, a total of 5,885,324 ordinary shares were presented for redemption in connection with the Extraordinary General Meeting. As of September 30, 2023, and December 31, 2022, the Company had $ 60,787,237 and $ 116,673,481 held in the Wilmington Trust account, respectively. 50,000 2,412,260 The funds held in the Trust Account will be invested only in United States government treasury bills, bonds or notes having a maturity of 180 days or less, or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company Act and that invest solely in United States government treasuries. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its income or other tax obligations, the proceeds will not be released from the Trust Account until the earlier of the completion of a Business Combination or the Company’s liquidation. Merger Agreement On April 12, 2023, Metal Sky entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Future Dao Group Holding Limited, a Cayman Islands exempted company (the “Future Dao”), and Future Dao League Limited, a Cayman Islands exempted company and wholly owned subsidiary of Future Dao (the “Merger Sub”). Pursuant to the Merger Agreement and subject to the terms and conditions set forth therein, (i) Merger Sub will merge with and into Metal Sky (the “First Merger”), with Metal Sky surviving the First Merger as a wholly owned subsidiary of Future Dao, and (ii) Metal Sky will merge with and into Future Dao (the “Second Merger” and together with the First Merger, the “Mergers”), with Future Dao surviving the Second Merger (the “Second Business Combination”). Immediately prior to the First Effective Time, Future Dao will effect a recapitalization of its equity securities (the “Recapitalization”) including a share split of each outstanding Future Dao Ordinary Share into such number of Future Dao Ordinary Shares, calculated in accordance with the terms of the Merger Agreement, such that, based on a value of $ 350 Termination of Merger Agreement On October 6, 2023, the parties to the Merger Agreement entered into a Termination of Agreement and Plan of Merger (the “Termination Agreement”), pursuant to which, among other things, the parties agreed to mutually terminate the Merger Agreement, pursuant to Section 10.01 (a) of the Merger Agreement, effective as of October 6, 2023 (the “Termination”). As a result of the Termination, the Merger Agreement will be of no further force and effect except as provided in Section 10.02 of the Merger Agreement, and the Transaction Agreements (as defined in the Merger Agreement) will either be terminated in accordance with their terms or be of no further force and effect. Neither party will be required to pay the other any fees or expenses as a result of the Termination. Metal Sky, Future Dao and Merger Sub have also agreed on behalf of themselves and their respective related parties, to a release of claims relating to the transactions contemplated under the Merger Agreement. Liquidity On April 5, 2022, the Company consummated the IPO of 11,500,000 10.00 115,000,000 Simultaneously with the consummation of the IPO, the Company sold to its Sponsor 330,000 10.00 3,300,000 Offering costs amounted to $ 5,704,741 2,300,000 2,875,000 529,741 25,000 115,682,250 As of September 30, 2023, the Company had $ 1,164 2,407,009 60,787,237 2,875,000 As of December 31, 2022, the Company had $ 178,652 71,597 116,673,481 2,875,000 In September 2021, the Company repurchased 1,437,500 25,000 2,875,000 25,000 375,000 Going Concern and Management Liquidity Plan As of September 30, 2023, the Company had $ 1,164 in cash and a working capital deficit of $ 2,407,009 , which excludes $ 60,787,237 of marketable securities held in the trust account and the liability for deferred underwriting commissions of $ 2,875,000 . The Company’s liquidity needs up to the closing of the IPO on April 5, 2022 had been satisfied through proceeds from notes payable and advances from related party and from the issuance of common stock. In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company with working capital. The Company’s management plans to continue its efforts to complete a Business Combination within the Combination Period after the closing of the Initial Public Offering. If our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our business combination. Moreover, we may need to obtain other financing either to complete our business combination or because we become obligated to redeem a significant number of our public shares upon consummation of our business combination, in which case we may issue additional securities or incur debt in connection with such business combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our business combination. If we are unable to complete our business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations. We have 22 months from the closing of the Initial Public Offering to consummate a Business Combination. It is uncertain that we will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there will be a mandatory liquidation and subsequent dissolution. On October 30, 2023 during the Extraordinary General Meeting, the shareholders approved an amendment to the company’s Amended and Restated Memorandum and Articles of Association to extend the date up to six (6) months which the company must consummate a business combination to August 5, 2024. As of September 30, 2023, the Company have approximately 10 months to consummate a business combination if fully extend the period of time as the Amended and Restated Memorandum and Articles of Association. In connection with the Company’s assessment of going concern considerations in accordance with the Accounting Standards Codification (the “ASC”) issued by Financial Accounting Standards Board (the “FASB”) 205-40, “Presentation of Financial Statements — Going Concern,” management has determined that mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time, which is considered to be one year from the issuance of the financial statements. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholders’ approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company have cash held in escrow $ 1,164 178,652 no Marketable Securities Held in Trust Account As per ASC Topic 230, “Statement of Cash Flows” (“ASC 230”), operating cash flows include interest and dividend income receipts related to investments in other reporting entities or deposits with financial institutions (i.e., returns on investment). Interest income earned on Investments held in Trust Account is fully reinvested into the Trust Account and therefore considered as an adjustment to reconcile net income/(loss) to net cash used in operating activities in the Statements of Cash Flows. Such interest income reinvested will be used to redeem all or a portion of the ordinary shares upon the completion of a business combination. At September 30, 2023, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. The Company’s marketable securities held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of marketable securities held in Trust Account are included in interest earned and unrealized gain on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. The securities are presented on the balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividends, interest earned, and unrealized gain on marketable securities held in Trust Account in the accompanying statements of operations and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets for identical assets. During the three months ended September 30, 2023, interest earned from the Trust account amounted to $ 773,011 516,036 256,975 During the nine months ended September 30, 2023, interest earned from the Trust account amounted to $ 2,322,337 2,065,362 256,975 During nine months ended September 30, 2023, $ 60,089,158 5,885,324 During the three months ended September 30, 2022, interest earned from the Trust account amounted to $ 519,917 298,932 220,985 During the nine months ended September 30, 2022, interest earned from the Trust account amounted to $ 680,827 459,842 220,985 Deferred Offering Costs Offering costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that are directly related to the IPO. As of April 5, 2021, offering costs amounted to $ 5,704,741 2,300,000 2,875,000 529,741 Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no no The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. Net Income (Loss) Per Share Net loss per share is computed by dividing net loss by the weighted average number of ordinary share outstanding during the period, excluding ordinary shares subject to forfeiture. The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 5,915,000 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The net income (loss) per share presented in the statement of operations is based on the following: Schedule of earning per shares For the For the For the For the Basic and Diluted net income (loss) per share: Non- Redeemable Non- Redeemable Non- Redeemable Non- Redeemable Numerators: Allocation of net loss $ (244,236 ) $ (427,865 ) $ (23,998 ) $ (86,106 ) $ (852,793 ) $ (1,625,813 ) $ (5,554,424 ) $ (13,548,017 ) Accretion of temporary equity - 561,466 - - - 1,880,576 - 18,820,172 Accretion of temporary equity – (interest earned and unrealized gain on trust account) - 773,011 - 519,917 - 2,322,337 - 680,827 Allocation of net income (loss) $ (244,236 ) $ 906,612 $ (23,998 ) $ 433,811 $ (852,793 ) $ 2,577,100 $ (5,554,424 ) $ 5,952,982 Denominators: Weighted-average shares outstanding 3,205,000 5,614,676 3,205,000 11,500,000 3,205,000 6,110,197 3,091,374 7,540,293 Basic and diluted net income (loss) per share $ (0.08 ) $ 0.16 $ (0.01 ) $ 0.04 $ (0.27 ) $ 0.42 $ (1.80 ) $ 0.79 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Recently Issued Accounting Standards On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022. Because there is a possibility that the Company may acquire a U.S. domestic corporation or engage in a transaction in which a domestic corporation becomes our parent or our affiliate and our securities will trade on Nasdaq following the date of this prospectus, we may become a “covered corporation”. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. Warrants The Company evaluates the Public and Private Warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in FASB ASC 480, and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both Public and Private Warrants will be classified in shareholders’ equity. Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption is presented at redemption value (plus any interest earned on the Trust Account) as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. |
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING | 9 Months Ended |
Sep. 30, 2023 | |
Initial Public Offering | |
INITIAL PUBLIC OFFERING | NOTE 3. INITIAL PUBLIC OFFERING On April 5, 2022, the Company sold 11,500,000 10.00 115,000,000 The Company granted the underwriter a 45-day option from the date of the IPO to purchase up to an additional 1,500,000 10.00 15,000,000 At September 30, 2023, the ordinary shares reflected in the balance sheet are reconciled in the following tables: Schedule of balance sheet are reconciled Gross proceeds from public shares $ 115,000,000 Less: Proceeds allocated to public rights (8,510,000 ) Proceeds allocated to public warrants (5,290,000 ) Allocation of offering costs related to ordinary shares (5,020,172 ) Redemption of Public Shares (60,089,158 ) Plus: Accretion of carrying value to redemption value 20,700,749 Subsequent measurement of ordinary shares subject to possible redemption (interest earned and unrealized gain on trust account) 3,995,818 Ordinary shares subject to possible redemption (plus any interest earned on the Trust Account) $ 60,787,237 |
PRIVATE PLACEMENT
PRIVATE PLACEMENT | 9 Months Ended |
Sep. 30, 2023 | |
Private Placement | |
PRIVATE PLACEMENT | NOTE 4. PRIVATE PLACEMENT The Sponsor has committed to purchase an aggregate of 300,000 330,000 10.00 3,000,000 3,300,000 |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 9 Months Ended |
Sep. 30, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares In May 2021, Harneys Fiduciary (Cayman) Limited transferred one ordinary share to the Sponsor for par value. On July 5, 2021 the Company redeemed the one share for par value and the Sponsor purchased 1,437,500 25,000 The 1,437,500 187,500 In September 2021, the Company repurchased 1,437,500 25,000 2,875,000 25,000 375,000 Administrative Services Agreement The Company entered into an administrative services agreement, commencing on April 5, 2022, through the earlier of the Company’s consummation of a Business Combination or its liquidation, to pay to the Sponsor a total of $ 10,000 For the three months ended as of September 30, 2023 and 2022, the Company incurred $ 30,000 30,000 For the nine months ended as of September 30, 2023 and 2022, the Company incurred $ 90,000 58,333 Sponsor Promissory Note— Related Party On June 15, 2021, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $ 300,000 On January 3, 2023, the Company issued a promissory note in the principal amount of up to $ 1,000,000 1,000,000 383,333 383,333 0.033 187,155 5,885,324 On April 18, 2023, the Company amended and restated Promissory Note (the Amended Promissory Note”) in order to increase the available principal amount from $1,000,000 to $ 2,500,000 . As of September 30, 2023 and December 31, 2022, the loans under the promissory notes were $ 1,935,248 and nil, respectively. Due to Related Party During the nine months ended September 30, 2023, the Company has amounts due to the Sponsor of $ 190,683 |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 9 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 6. COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In the beginning of February 2022, the Russian Federation and Belarus commenced a military action against the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. On August 16, 2022, IR Act was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022. Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. Because there is a possibility that the Company may acquire a U.S. domestic corporation or engage in a transaction in which a domestic corporation becomes our parent or our affiliate and our securities will trade on Nasdaq following the date of this prospectus, we may become a “covered corporation”. Registration Rights The holders of the Founder Shares will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the IPO. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement On August 10, 2021, the Company engaged Ladenburg Thalmann & Co. Inc. as its underwriter. The Company will grant the underwriters a 45-day option to purchase up to 1,500,000 Ladenburg Thalmann has agreed to revise the warrant agreement that the warrant is exercisable on the later of one year after the closing of this offering or the consummation of an initial business combination. The underwriters will be entitled to a cash underwriting discount of: (i) two percent ( 2.0 2,300,000 2.50 2,875,000 2,875,000 Professional Fees The Company has paid professional fees of $ 25,000 The Company entered into the agreement with a retainer of $5,000 per month starting from April 1, 2022. 15,000 15,000 45,000 30,000 On April 12, 2023, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Future Dao Group Holding Limited, a Cayman Islands exempted company and its subsidiary (the “Future Dao”). Due to these recapitalization and business combination activities, the Company incurred professional fees with amounts of approximately $ 3,500 163,000 |
SHAREHOLDERS_ DEFICIT
SHAREHOLDERS’ DEFICIT | 9 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
SHAREHOLDERS’ DEFICIT | NOTE 7. SHAREHOLDERS’ DEFICIT Ordinary Shares The Company is authorized to issue 50,000,000 0.001 Holders of the ordinary shares are entitled to one vote for each ordinary share. 3,205,000 11,500,000 375,000 Public Warrants Each warrant entitles the holder to purchase one ordinary share at a price of $ 11.50 0.01 30 60 In addition, if (a) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by our board of directors), (b) the aggregate gross proceeds from such issuances represent more than 60 20 9.20 180 |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 8. Fair Value Measurements The Company complies with ASC 820, “Fair Value Measurements”, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. ASC 820 determines fair value to be the price that would be received to sell an asset or would be paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. On September 30, 2023, assets held in the trust account were entirely comprised of marketable securities. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis on September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value. Schedule of Assets Measured at Fair Value on a Recurring basis Assets September 30, 2023 Quoted Significant Significant Marketable Securities held in Trust Account $ 60,787,237 $ - $ - Assets December 31, 2022 Quoted Significant Significant Marketable Securities held in Trust Account $ 116,673,481 $ - $ - |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 9 Months Ended |
Sep. 30, 2023 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 9. SUBSEQUENT EVENTS In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred up to November 14, 2023, the date the financial statements were available to issue. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements except the following: Termination of Merger Agreement On October 6, 2023, the parties to the Merger Agreement entered into a Termination of Agreement and Plan of Merger (the “Termination Agreement”), pursuant to which, among other things, the parties agreed to mutually terminate the Merger Agreement, pursuant to Section 10.01 (a) of the Merger Agreement, effective as of October 6, 2023 (the “Termination”). As a result of the Termination, the Merger Agreement will be of no further force and effect except as provided in Section 10.02 of the Merger Agreement, and the Transaction Agreements (as defined in the Merger Agreement) will either be terminated in accordance with their terms or be of no further force and effect. Neither party will be required to pay the other any fees or expenses as a result of the Termination. Metal Sky, Future Dao and Merger Sub have also agreed on behalf of themselves and their respective related parties, to a release of claims relating to the transactions contemplated under the Merger Agreement. Amended Articles of Association On October 30, 2023, Metal Sky Star Acquisition Corporation (the “Company” or “Metal Sky Star”) held its Extraordinary General Meeting (the “Extraordinary General Meeting”) at which the Company’s shareholders approved proposals to (i) amend the Company’s amended and restated memorandum and articles of association to extend the date by which the Company has to consummate a business combination to August 5, 2024 and to reduce the amount of the fee to extend such time period (the “Charter Amendment Proposal”) and (ii) amend the Investment Management Trust Agreement dated March 30, 2022 among the Company, Wilmington Trust, National Association (the “Trustee”) and Vstock Transfer LLC (“Vstock”) to reflect the Charter Amendment Proposal. Following the Extraordinary General Meeting, effective as of October 31, 2023, the Company, the Trustee and Vstock entered into an amendment to the Investment Management Trust Agreement (the “Amendment Agreement”) to change the date on which the Company’s ability to complete a business combination may be extended by up to six (6) additional increments of one-month each until August 5, 2024, subject to the payment into the Trust Account by the Sponsor (or its designees or affiliates) of an amount for each one-month extension equal to the lesser of (i) $ 50,000 0.033 Public Shares Redemption In connection with the shareholders meeting to vote for the proposal to amend the Company’s amended and restated memorandum and articles of association, the public shares are entitled to exercise the redemption right and 2,412,260 3,202,416 Related Party Transactions On October 9, 2023, the Company drew down $ 187,155 On November 6, 2023, the Company drew down $ 50,000 |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying financial statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholders’ approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company have cash held in escrow $ 1,164 178,652 no |
Marketable Securities Held in Trust Account | Marketable Securities Held in Trust Account As per ASC Topic 230, “Statement of Cash Flows” (“ASC 230”), operating cash flows include interest and dividend income receipts related to investments in other reporting entities or deposits with financial institutions (i.e., returns on investment). Interest income earned on Investments held in Trust Account is fully reinvested into the Trust Account and therefore considered as an adjustment to reconcile net income/(loss) to net cash used in operating activities in the Statements of Cash Flows. Such interest income reinvested will be used to redeem all or a portion of the ordinary shares upon the completion of a business combination. At September 30, 2023, substantially all of the assets held in the Trust Account were held in U.S. Treasury securities. The Company’s marketable securities held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of marketable securities held in Trust Account are included in interest earned and unrealized gain on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. The securities are presented on the balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividends, interest earned, and unrealized gain on marketable securities held in Trust Account in the accompanying statements of operations and are automatically reinvested. The fair value for these securities is determined using quoted market prices in active markets for identical assets. During the three months ended September 30, 2023, interest earned from the Trust account amounted to $ 773,011 516,036 256,975 During the nine months ended September 30, 2023, interest earned from the Trust account amounted to $ 2,322,337 2,065,362 256,975 During nine months ended September 30, 2023, $ 60,089,158 5,885,324 During the three months ended September 30, 2022, interest earned from the Trust account amounted to $ 519,917 298,932 220,985 During the nine months ended September 30, 2022, interest earned from the Trust account amounted to $ 680,827 459,842 220,985 |
Deferred Offering Costs | Deferred Offering Costs Offering costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that are directly related to the IPO. As of April 5, 2021, offering costs amounted to $ 5,704,741 2,300,000 2,875,000 529,741 |
Income Taxes | Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no no The Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. |
Net Income (Loss) Per Share | Net Income (Loss) Per Share Net loss per share is computed by dividing net loss by the weighted average number of ordinary share outstanding during the period, excluding ordinary shares subject to forfeiture. The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 5,915,000 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The net income (loss) per share presented in the statement of operations is based on the following: Schedule of earning per shares For the For the For the For the Basic and Diluted net income (loss) per share: Non- Redeemable Non- Redeemable Non- Redeemable Non- Redeemable Numerators: Allocation of net loss $ (244,236 ) $ (427,865 ) $ (23,998 ) $ (86,106 ) $ (852,793 ) $ (1,625,813 ) $ (5,554,424 ) $ (13,548,017 ) Accretion of temporary equity - 561,466 - - - 1,880,576 - 18,820,172 Accretion of temporary equity – (interest earned and unrealized gain on trust account) - 773,011 - 519,917 - 2,322,337 - 680,827 Allocation of net income (loss) $ (244,236 ) $ 906,612 $ (23,998 ) $ 433,811 $ (852,793 ) $ 2,577,100 $ (5,554,424 ) $ 5,952,982 Denominators: Weighted-average shares outstanding 3,205,000 5,614,676 3,205,000 11,500,000 3,205,000 6,110,197 3,091,374 7,540,293 Basic and diluted net income (loss) per share $ (0.08 ) $ 0.16 $ (0.01 ) $ 0.04 $ (0.27 ) $ 0.42 $ (1.80 ) $ 0.79 |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. |
Recently Issued Accounting Standards | Recently Issued Accounting Standards On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act applies only to repurchases that occur after December 31, 2022. Because there is a possibility that the Company may acquire a U.S. domestic corporation or engage in a transaction in which a domestic corporation becomes our parent or our affiliate and our securities will trade on Nasdaq following the date of this prospectus, we may become a “covered corporation”. Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements. |
Warrants | Warrants The Company evaluates the Public and Private Warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in FASB ASC 480, and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. Pursuant to such evaluation, both Public and Private Warrants will be classified in shareholders’ equity. |
Ordinary Shares Subject to Possible Redemption | Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption is presented at redemption value (plus any interest earned on the Trust Account) as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Schedule of earning per shares | Schedule of earning per shares For the For the For the For the Basic and Diluted net income (loss) per share: Non- Redeemable Non- Redeemable Non- Redeemable Non- Redeemable Numerators: Allocation of net loss $ (244,236 ) $ (427,865 ) $ (23,998 ) $ (86,106 ) $ (852,793 ) $ (1,625,813 ) $ (5,554,424 ) $ (13,548,017 ) Accretion of temporary equity - 561,466 - - - 1,880,576 - 18,820,172 Accretion of temporary equity – (interest earned and unrealized gain on trust account) - 773,011 - 519,917 - 2,322,337 - 680,827 Allocation of net income (loss) $ (244,236 ) $ 906,612 $ (23,998 ) $ 433,811 $ (852,793 ) $ 2,577,100 $ (5,554,424 ) $ 5,952,982 Denominators: Weighted-average shares outstanding 3,205,000 5,614,676 3,205,000 11,500,000 3,205,000 6,110,197 3,091,374 7,540,293 Basic and diluted net income (loss) per share $ (0.08 ) $ 0.16 $ (0.01 ) $ 0.04 $ (0.27 ) $ 0.42 $ (1.80 ) $ 0.79 |
INITIAL PUBLIC OFFERING (Tables
INITIAL PUBLIC OFFERING (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Initial Public Offering | |
Schedule of balance sheet are reconciled | Schedule of balance sheet are reconciled Gross proceeds from public shares $ 115,000,000 Less: Proceeds allocated to public rights (8,510,000 ) Proceeds allocated to public warrants (5,290,000 ) Allocation of offering costs related to ordinary shares (5,020,172 ) Redemption of Public Shares (60,089,158 ) Plus: Accretion of carrying value to redemption value 20,700,749 Subsequent measurement of ordinary shares subject to possible redemption (interest earned and unrealized gain on trust account) 3,995,818 Ordinary shares subject to possible redemption (plus any interest earned on the Trust Account) $ 60,787,237 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Assets Measured at Fair Value on a Recurring basis | Schedule of Assets Measured at Fair Value on a Recurring basis Assets September 30, 2023 Quoted Significant Significant Marketable Securities held in Trust Account $ 60,787,237 $ - $ - Assets December 31, 2022 Quoted Significant Significant Marketable Securities held in Trust Account $ 116,673,481 $ - $ - |
DESCRIPTION OF ORGANIZATION A_2
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details Narrative) - USD ($) | 1 Months Ended | 9 Months Ended | ||||
Apr. 05, 2022 | Jul. 05, 2021 | Sep. 30, 2021 | Sep. 30, 2023 | Apr. 12, 2023 | Dec. 31, 2022 | |
Subsidiary, Sale of Stock [Line Items] | ||||||
Proceeds from IPO and Private Placement | $ 115,682,250 | |||||
[custom:RedemptionsShares] | 5,885,324 | |||||
Asset, Held-in-Trust, Noncurrent | $ 60,787,237 | $ 116,673,481 | ||||
Trust Account amount | $ 50,000 | |||||
Ordinary shares | 2,412,260 | |||||
Merger Agreement value | $ 350,000,000 | |||||
Subscription of ordinary shares | $ 25,000 | |||||
Cash | $ 1,164 | 178,652 | ||||
Working Capital | 2,407,009 | 71,597 | ||||
Marketable Securities | 60,787,237 | 116,673,481 | ||||
Deferred underwriting commissions | $ 2,875,000 | $ 2,875,000 | ||||
Founder [Member] | ||||||
Subsidiary, Sale of Stock [Line Items] | ||||||
Stock Repurchased and Retired During Period, Shares | 1,437,500 | 1,437,500 | ||||
Stock Repurchased During Period, Value | $ 25,000 | |||||
Ordinary shares subject to forfeiture | 187,500 | |||||
Sponsor [Member] | ||||||
Subsidiary, Sale of Stock [Line Items] | ||||||
Stock Issued During Period, Shares, Issued for Services | 2,875,000 | |||||
Stock Issued During Period, Value, New Issues | $ 25,000 | |||||
IPO [Member] | ||||||
Subsidiary, Sale of Stock [Line Items] | ||||||
Sale of units in initial public offering | 11,500,000 | |||||
Sale of units per share | $ 10 | |||||
Sale of units in initial public offering aggragate amount | $ 115,000,000 | |||||
Offering costs | 5,704,741 | |||||
Underwriting fees | 2,300,000 | |||||
Deferred underwriting fees | 2,875,000 | |||||
Other offering costs | $ 529,741 | |||||
Over-Allotment Option [Member] | ||||||
Subsidiary, Sale of Stock [Line Items] | ||||||
Sale of units in initial public offering | 330,000 | |||||
Sale of units per share | $ 10 | |||||
Sale of units in initial public offering aggragate amount | $ 3,300,000 | |||||
Ordinary shares subject to forfeiture | 375,000 | 375,000 | ||||
Over-Allotment Option [Member] | Underwriters [Member] | ||||||
Subsidiary, Sale of Stock [Line Items] | ||||||
Sale of units in initial public offering | 1,500,000 | |||||
Sale of units per share | $ 10 | |||||
Sale of units in initial public offering aggragate amount | $ 15,000,000 | |||||
Private Placement [Member] | ||||||
Subsidiary, Sale of Stock [Line Items] | ||||||
Sale of units in initial public offering | 300,000 | |||||
Sale of units in initial public offering aggragate amount | $ 3,000,000 | |||||
Proceeds from IPO and Private Placement | $ 115,682,250 |
SUMMARY OF SIGNIFICANT ACCOUN_4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Non Redeemable Shares [Member] | ||||
Numerators: | ||||
Allocation of net loss | $ (244,236) | $ (23,998) | $ (852,793) | $ (5,554,424) |
Accretion of temporary equity | ||||
Accretion of temporary equity – (interest earned and unrealized gain on trust account) | ||||
Allocation of net income (loss) | $ (244,236) | $ (23,998) | $ (852,793) | $ (5,554,424) |
Denominators: | ||||
Weighted-average shares outstanding | 3,205,000 | 3,205,000 | 3,205,000 | 3,091,374 |
Basic and diluted net income (loss) per share | $ (0.08) | $ (0.01) | $ (0.27) | $ (1.80) |
Redeemable Shares [Member] | ||||
Numerators: | ||||
Allocation of net loss | $ (427,865) | $ (86,106) | $ (1,625,813) | $ (13,548,017) |
Accretion of temporary equity | 561,466 | 1,880,576 | 18,820,172 | |
Accretion of temporary equity – (interest earned and unrealized gain on trust account) | 773,011 | 519,917 | 2,322,337 | 680,827 |
Allocation of net income (loss) | $ 906,612 | $ 433,811 | $ 2,577,100 | $ 5,952,982 |
Denominators: | ||||
Weighted-average shares outstanding | 5,614,676 | 11,500,000 | 6,110,197 | 7,540,293 |
Basic and diluted net income (loss) per share | $ 0.16 | $ 0.04 | $ 0.42 | $ 0.79 |
SUMMARY OF SIGNIFICANT ACCOUN_5
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Apr. 05, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Subsidiary, Sale of Stock [Line Items] | ||||||
Cash in escrow | $ 1,164 | $ 1,164 | $ 178,652 | |||
Cash equivalents | 0 | 0 | 0 | |||
Total other income | 773,011 | $ 519,917 | 2,322,337 | $ 680,827 | ||
Interest earned on marketable securities held in trust account | 516,036 | 298,932 | 2,065,362 | 459,842 | ||
Unrealized gained on marketable securities held in trust account | 256,975 | $ 220,985 | 256,975 | $ 220,985 | ||
Withdrawn from trust account | $ 60,089,158 | |||||
Trust account for redemption of public shares | 5,885,324 | |||||
Unrecognized tax benefits | 0 | $ 0 | 0 | |||
Accrued for interest and penalties | $ 0 | $ 0 | $ 0 | |||
Warrants exercisable | 5,915,000 | |||||
IPO [Member] | ||||||
Subsidiary, Sale of Stock [Line Items] | ||||||
Offering costs | $ 5,704,741 | |||||
Underwriting fees | 2,300,000 | |||||
Deferred underwriting fees | 2,875,000 | |||||
Other offering costs | $ 529,741 |
INITIAL PUBLIC OFFERING (Detail
INITIAL PUBLIC OFFERING (Details) - USD ($) | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Initial Public Offering | ||
Gross proceeds from public shares | $ 115,000,000 | |
Proceeds allocated to public rights | (8,510,000) | |
Proceeds allocated to public warrants | (5,290,000) | |
Allocation of offering costs related to ordinary shares | (5,020,172) | |
Redemption of Public Shares | (60,089,158) | |
Accretion of carrying value to redemption value | 20,700,749 | |
Subsequent measurement of ordinary shares subject to possible redemption (interest earned and unrealized gain on trust account) | 3,995,818 | |
Ordinary shares subject to possible redemption (plus any interest earned on the Trust Account) | $ 60,787,237 |
INITIAL PUBLIC OFFERING (Deta_2
INITIAL PUBLIC OFFERING (Details Narrative) | Apr. 05, 2022 USD ($) $ / shares shares |
IPO [Member] | |
Subsidiary, Sale of Stock [Line Items] | |
Sale of units in initial public offering | shares | 11,500,000 |
Sale of units per share | $ / shares | $ 10 |
Sale of units in initial public offering aggragate amount | $ | $ 115,000,000 |
Over-Allotment Option [Member] | |
Subsidiary, Sale of Stock [Line Items] | |
Sale of units in initial public offering | shares | 330,000 |
Sale of units per share | $ / shares | $ 10 |
Sale of units in initial public offering aggragate amount | $ | $ 3,300,000 |
Over-Allotment Option [Member] | Underwriters [Member] | |
Subsidiary, Sale of Stock [Line Items] | |
Sale of units in initial public offering | shares | 1,500,000 |
Sale of units per share | $ / shares | $ 10 |
Sale of units in initial public offering aggragate amount | $ | $ 15,000,000 |
PRIVATE PLACEMENT (Details Narr
PRIVATE PLACEMENT (Details Narrative) | Apr. 05, 2022 USD ($) $ / shares shares |
Private Placement [Member] | |
Subsidiary, Sale of Stock [Line Items] | |
Sale of units in initial public offering | shares | 300,000 |
Sale of units in initial public offering aggragate amount | $ 3,000,000 |
Over-Allotment Option [Member] | |
Subsidiary, Sale of Stock [Line Items] | |
Sale of units in initial public offering | shares | 330,000 |
Sale of units per share | $ / shares | $ 10 |
Sale of units in initial public offering aggragate amount | $ 3,300,000 |
IPO [Member] | |
Subsidiary, Sale of Stock [Line Items] | |
Sale of units in initial public offering | shares | 11,500,000 |
Sale of units per share | $ / shares | $ 10 |
Sale of units in initial public offering aggragate amount | $ 115,000,000 |
IPO [Member] | Sponsor [Member] | |
Subsidiary, Sale of Stock [Line Items] | |
Proceeds from private placement | $ 3,300,000 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended | ||||||||||
Feb. 01, 2023 | Apr. 05, 2022 | Jul. 05, 2021 | Sep. 30, 2021 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Apr. 18, 2023 | Jan. 04, 2023 | Jan. 03, 2023 | Dec. 31, 2022 | Jun. 15, 2021 | |
Related Party Transaction [Line Items] | |||||||||||||
Related party service fee | $ 10,000 | ||||||||||||
Administrative Fees Expense | $ 30,000 | $ 30,000 | $ 90,000 | $ 58,333 | |||||||||
Extension fee | $ 187,155 | ||||||||||||
Number of public shares redeemed | 5,885,324 | ||||||||||||
[custom:PromissoryNoteRelatedParty-0] | 1,935,248 | 1,935,248 | $ 0 | ||||||||||
Due to related party | $ 190,683 | $ 190,683 | |||||||||||
Over-Allotment Option [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Ordinary shares subject to forfeiture | 375,000 | 375,000 | |||||||||||
Founder [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Stock repurchased during period, shares | 1,437,500 | 1,437,500 | |||||||||||
Ordinary shares subject to forfeiture | 187,500 | ||||||||||||
Stock Repurchased During Period, Value | $ 25,000 | ||||||||||||
Sponsor [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Number of shares forfeited | 1,437,500 | ||||||||||||
Value of shares forfeited | $ 25,000 | ||||||||||||
Stock Issued During Period, Shares, Issued for Services | 2,875,000 | ||||||||||||
Stock Issued During Period, Value, New Issues | $ 25,000 | ||||||||||||
Principal amount | $ 300,000 | ||||||||||||
M Star Management Corp [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Principal amount | $ 2,500,000 | $ 1,000,000 | |||||||||||
Payment of extesnsion fee | $ 383,333 | $ 1,000,000 | |||||||||||
Amount diposited into trust account | $ 383,333 | ||||||||||||
Price per public share | $ 0.033 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Apr. 05, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Defined Benefit Plan Disclosure [Line Items] | ||||||
Deferred underwriting commissions | $ 2,875,000 | $ 2,875,000 | $ 2,875,000 | |||
Professional fees | $ 25,000 | 3,500 | $ 163,000 | |||
Monthly payment, description | The Company entered into the agreement with a retainer of $5,000 per month starting from April 1, 2022. | |||||
Fees for services | $ 15,000 | $ 15,000 | $ 45,000 | $ 30,000 | ||
Over-Allotment Option [Member] | ||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||
Sale of units in initial public offering | 330,000 | |||||
IPO [Member] | ||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||
Sale of units in initial public offering | 11,500,000 | |||||
Percentage of cash underwriting commission | 2% | |||||
Percentage of underwriting deferred commission | 2.50% | |||||
Underwriters [Member] | Over-Allotment Option [Member] | ||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||
Sale of units in initial public offering | 1,500,000 | |||||
Ladenburg Thalmann [Member] | Over-Allotment Option [Member] | ||||||
Defined Benefit Plan Disclosure [Line Items] | ||||||
Proceeds from Issuance Initial Public Offering | $ 2,300,000 |
SHAREHOLDERS_ DEFICIT (Details
SHAREHOLDERS’ DEFICIT (Details Narrative) - $ / shares | 1 Months Ended | 9 Months Ended | |
Sep. 30, 2021 | Sep. 30, 2023 | Dec. 31, 2022 | |
Subsidiary, Sale of Stock [Line Items] | |||
Common stock, shares authorized | 50,000,000 | 50,000,000 | |
Common stock, par value per share | $ 0.001 | $ 0.001 | |
Common stock, voting rights | Holders of the ordinary shares are entitled to one vote for each ordinary share. | ||
Common Stock, shares issued | 3,205,000 | 3,205,000 | |
Common stock, shares outstanding | 3,205,000 | 3,205,000 | |
Ordinary shares subject to possible redemption, shares | 5,614,676 | 11,500,000 | |
Warrant [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Share Price | $ 11.50 | ||
Class of warrants or rights redemption price per share | $ 0.01 | ||
Minimum notice period to be given to warrant holders prior to redemption | 30 days | ||
Class of warrants or rights period within the registration shall be effective from the consummation of business combination | 60 days | ||
Percentage of funds raised to be used for consummating business combination | 60% | ||
Number of consecutive trading days for determining the volume weighted average price of share | 20 days | ||
Volume weighted average price per share | $ 9.20 | ||
Class of warrants or rights exercise price percentage | 180% | ||
Over-Allotment Option [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Ordinary shares subject to forfeiture | 375,000 | 375,000 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable Securities held in Trust Account | $ 60,787,237 | $ 116,673,481 |
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable Securities held in Trust Account | 60,787,237 | 116,673,481 |
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable Securities held in Trust Account | ||
Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Marketable Securities held in Trust Account |
SUBSEQUENT EVENTS (Details Narr
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($) | Nov. 06, 2023 | Oct. 31, 2023 | Oct. 09, 2023 |
Subsequent Event [Line Items] | |||
Remaining public shares amount | $ 50,000 | ||
Public share price | $ 0.033 | ||
Redemption public shares | 2,412,260 | ||
Unredemed public shares | 3,202,416 | ||
Transaction cost | $ 50,000 | $ 187,155 |